More than 80% of no-option chronic limb-threatening ischemia patients avoided amputation for 6 months after the procedure ...

The quality of care in nursing homes is often discussed in terms of staffing levels, reimbursement and regulatory oversight.

We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. 19 Table 1 summarizes the eligibility criteria. Study design Quantitative (interventional or ...

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

Framework’s ultra-repairable PCs are, by their nature, open platforms. So it seemed strange for the company’s founder and CEO, Nirav Patel, to call its latest “Pro”-level Framework Laptop with its new ...

PCWorld highlights the Framework Laptop 13 Pro’s transformation into a premium device with solid aluminum construction, addressing previous models’ build quality issues while maintaining modular ...

If you buy something from a Verge link, Vox Media may earn a commission. See our ethics statement. is a senior editor and founding member of The Verge who covers gadgets, games, and toys. He spent 15 ...

Framework, the company that makes laptops designed for optimal repairability, announced a new version of its main product, a 13-inch-screen laptop. It’s called the Framework Laptop 13 Pro, and it has ...

We’ve seen enough product announcements from Framework at this point that today’s updates feel more or less routine. The biggest new thing is an updated motherboard with Intel’s Core Ultra Series 3 ...

Framework has been selling and shipping its modular, repairable, upgradable Laptop 13 for five years now, and in that time, it has released six distinct versions of its system board, each using fresh ...

Framework CEO Nirav Patel showed off his company’s latest modular, repairable laptops in San Francisco on Tuesday. The headliner is the new Laptop 13 Pro, which is its first machine fully machined out ...

Boehringer Ingelheim and Amgen have both canned early-stage immunology candidates after the prospects showed little clinical promise. Germany drugmaker Boehringer has halted development of the oral ...